Veradermics Inc logo

Veradermics Inc

MANE
Healthcare|Biotechnology|USA
$119.60
-5.31 (-4.25%)
Tangible Book
$10.46

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, 12.99, 57.33, 226.67, 528.87 ], "ebit_estimate": [ -117.44, -124.12, -82.84, -14.1, 235 ], "ebitda_estimate": [ -118.71, -129.3, 131.7, null, null ], "net_income_estimate": [ -111.07, -118.87, -131.13, -9.63, 240.63 ], "per_share_eps_estimate": [ -2.94, -2.64, -2.86, -0.28, 5.14 ], "eps_nri_estimate": [ -2.99, -2.69, -2.8, -0.14, 5.23 ], "dividend_estimate": [ 5.55, 5.55, 5.55, 11.1, 11.1 ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -101.87, -115.03, -74.55, -11.63, 231.93 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -85.01, -21.36, 12.2, null, null ], "gross_margin_estimate": [ null, null, 90, 92.5, 92.5 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 23.27 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -21.54, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, null, null, null, null, null, null ], "ebit_estimate": [ -29.59, -29, -28.97, -24, -28, -30, -39 ], "ebitda_estimate": [ -27.93, -29.68, -31.24, null, null, null, null ], "net_income_estimate": [ -27.99, -26.84, -26.95, -22, -25, -28, -37 ], "per_share_eps_estimate": [ -0.61, -0.56, -0.58, -0.53, -0.6, -0.66, -0.89 ], "eps_nri_estimate": [ -0.67, -0.63, -0.63, -0.53, -0.6, -0.66, -0.89 ], "dividend_estimate": [ 2.8, 2.8, 2.8, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -25.77, -24.8, -25.93, -22, -25, -28, -37 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -21.54, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-07 16:39:36
2026-06-16 17:31:42